Chemed Co. (NYSE:CHE) Director George J. Walsh III Sells 400 Shares

Chemed Co. (NYSE:CHE - Get Free Report) Director George J. Walsh III sold 400 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company's stock, valued at approximately $1,819,893.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Chemed Trading Down 0.2 %

Shares of Chemed stock opened at $599.04 on Friday. The company has a fifty day moving average price of $574.54 and a 200 day moving average price of $576.44. Chemed Co. has a twelve month low of $497.36 and a twelve month high of $654.62. The stock has a market cap of $9.07 billion, a price-to-earnings ratio of 32.24, a price-to-earnings-growth ratio of 2.40 and a beta of 0.44.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.59 by ($0.12). The company had revenue of $595.88 million during the quarter, compared to analyst estimates of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. Chemed's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $4.71 EPS. Analysts forecast that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend


Revolutionary Tech Alert: How Elon Musk is Changing Lives
"Elon Musk's Neuralink just received FDA breakthrough status for a revolutionary device designed to restore vision to those who've lost it entirely. And the first human clinical trials have opened for recruitment.
Click here to see it.


The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Monday, August 12th were given a dividend of $0.50 per share. This is a boost from Chemed's previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Monday, August 12th. Chemed's payout ratio is presently 10.76%.

Institutional Investors Weigh In On Chemed

A number of large investors have recently added to or reduced their stakes in CHE. Thrivent Financial for Lutherans increased its holdings in Chemed by 300.3% during the 2nd quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company's stock worth $63,249,000 after purchasing an additional 87,449 shares during the last quarter. Epoch Investment Partners Inc. grew its position in shares of Chemed by 85.2% during the fourth quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company's stock worth $88,977,000 after buying an additional 70,001 shares in the last quarter. Impax Asset Management Group plc increased its stake in shares of Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company's stock worth $172,510,000 after buying an additional 51,974 shares during the last quarter. ProShare Advisors LLC raised its holdings in Chemed by 6,288.9% in the first quarter. ProShare Advisors LLC now owns 50,600 shares of the company's stock valued at $32,482,000 after acquiring an additional 49,808 shares in the last quarter. Finally, TD Asset Management Inc boosted its stake in Chemed by 23.9% during the 1st quarter. TD Asset Management Inc now owns 254,953 shares of the company's stock valued at $163,662,000 after acquiring an additional 49,176 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

About Chemed

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Recommended Stories

Insider Buying and Selling by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Chemed?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Chemed and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles